Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Different Dosing and Feeding Intervals on the Pharmacokinetic Parameters of Herombopag Olamine Tablets

Trial Profile

Effects of Different Dosing and Feeding Intervals on the Pharmacokinetic Parameters of Herombopag Olamine Tablets

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Aug 2018

At a glance

  • Drugs Hetrombopag (Primary)
  • Indications Idiopathic thrombocytopenic purpura
  • Focus Adverse reactions; Registrational
  • Sponsors Jiangsu Hengrui Medicine Co.
  • Most Recent Events

    • 01 Aug 2018 Status changed from not yet recruiting to recruiting.
    • 31 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top